1. Home
  2. GABC vs NBTX Comparison

GABC vs NBTX Comparison

Compare GABC & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo German American Bancorp Inc.

GABC

German American Bancorp Inc.

HOLD

Current Price

$51.06

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$37.69

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GABC
NBTX
Founded
1910
2003
Country
United States
France
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
GABC
NBTX
Price
$51.06
$37.69
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$47.67
$36.00
AVG Volume (30 Days)
152.3K
108.1K
Earning Date
04-27-2026
03-31-2026
Dividend Yield
2.88%
N/A
EPS Growth
8.13
N/A
EPS
0.88
N/A
Revenue
$487,401,000.00
N/A
Revenue This Year
$16.78
$58.17
Revenue Next Year
$3.98
N/A
P/E Ratio
$58.00
N/A
Revenue Growth
37.80
N/A
52 Week Low
$37.19
$6.97
52 Week High
$52.23
$57.14

Technical Indicators

Market Signals
Indicator
GABC
NBTX
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
GABC
NBTX

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The lines of business include the core banking segment and the wealth management segment. The core banking segment involves attracting deposits from the general public and using those funds to originate consumer, commercial, and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services, which involve providing trust, investment advisory, brokerage, and retirement planning services to customers. The company generates the majority of its revenue from the core banking segment.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: